IFP Advisors’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,369
| Closed | -$12K | – | 4963 |
|
|
2022
Q3 | $12K | Hold |
4,369
| – | – | ﹤0.01% | 3540 |
|
|
2022
Q2 | $12K | Hold |
4,369
| – | – | ﹤0.01% | 3290 |
|
|
2022
Q1 | $12K | Buy |
4,369
+2,369
| +118% | +$8.59K | ﹤0.01% | 3290 |
|
|
2021
Q4 | $7K | Sell |
2,000
-1,715
| -46% | -$6K | ﹤0.01% | 2385 |
|
|
2021
Q3 | $13K | Buy |
3,715
+750
| +25% | +$3.03K | ﹤0.01% | 2184 |
|
|
2021
Q2 | $12K | Hold |
2,965
| – | – | ﹤0.01% | 2161 |
|
|
2021
Q1 | $12K | Buy |
2,965
+1,250
| +73% | +$5.42K | ﹤0.01% | 2080 |
|
|
2020
Q4 | $7K | Hold |
1,715
| – | – | ﹤0.01% | 2219 |
|
|
2020
Q3 | $5K | Hold |
1,715
| – | – | ﹤0.01% | 2210 |
|
|
2020
Q2 | $5K | Sell |
1,715
-3,000
| -64% | -$8.37K | ﹤0.01% | 2123 |
|
|
2020
Q1 | $11K | Hold |
4,715
| – | – | ﹤0.01% | 1745 |
|
|
2019
Q4 | $22K | Sell |
4,715
-28,000
| -86% | -$115K | ﹤0.01% | 1592 |
|
|
2019
Q3 | $111K | Buy |
+32,715
| New | +$108K | 0.01% | 1013 |
|
|
2019
Q1 | $0 | Sell |
95
-32,350
| -100% | -$105K | ﹤0.01% | 3676 |
|
|
2018
Q4 | $85K | Sell |
32,445
-39,720
| -55% | -$131K | 0.01% | 1291 |
|
|
2018
Q3 | $242K | Buy |
72,165
+15,138
| +27% | +$46.8K | 0.01% | 980 |
|
|
2018
Q2 | $147K | Buy |
57,027
+56,932
| +59,928% | +$142K | 0.01% | 1253 |
|
|
2018
Q1 | $0 | Hold |
95
| – | – | ﹤0.01% | 3869 |
|
|
2017
Q4 | $0 | Sell |
95
-14,000
| -99% | -$30.5K | ﹤0.01% | 4199 |
|
|
2017
Q3 | $46K | Hold |
14,095
| – | – | ﹤0.01% | 2044 |
|
|
2017
Q2 | $45K | Hold |
14,095
| – | – | ﹤0.01% | 2041 |
|
|
2017
Q1 | $40K | Hold |
14,095
| – | – | ﹤0.01% | 2061 |
|
|
2016
Q4 | $33K | Hold |
14,095
| – | – | ﹤0.01% | 2134 |
|
|
2016
Q3 | $24K | Hold |
14,095
| – | – | ﹤0.01% | 2306 |
|
|
2016
Q2 | $15K | Buy |
14,095
+14,000
| +14,737% | +$13.5K | ﹤0.01% | 2552 |
|
|
2016
Q1 | $0 | Sell |
95
-14,000
| -99% | -$13.5K | ﹤0.01% | 3670 |
|
|
2015
Q4 | $17K | Buy |
+14,095
| New | +$19.6K | ﹤0.01% | 2274 |
|
IFP Advisors's ATRS Position: Q4 2022 in Review
IFP Advisors sold out of Antares Pharma, Inc. (ATRS) in Q4 2022, closing a stake of 4,369 shares — an estimated $12K sold.
IFP Advisors first reported a position in ATRS in Q4 2015 and held it in 27 quarters. The position peaked at $242K in Q3 2018. 0 funds tracked by Wall St. Rank hold ATRS as of Q4 2022.
- IFP Advisors reported no remaining Antares Pharma, Inc. position as of Q4 2022 after selling out during the quarter.
- IFP Advisors sold 4,369 Antares Pharma, Inc. shares in Q4 2022, an estimated $12K.
- IFP Advisors first reported a position in Antares Pharma, Inc. in Q4 2015 and held it in 27 quarters.
- IFP Advisors's Antares Pharma, Inc. position peaked at $242K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2022.
Based on IFP Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.